In addition, at a translational level, our findings are in line with reports that the low expression of GPER1 in breast cancer is related to adverse patient survival [42], while several in vitro experiments have found that it can attenuate the growth of ER-positive breast cancer cell lines [30]. The gene discussed is ESR1; the disease is breast carcinoma.